[
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "4-1BB",
        "binding_metric": "Kd",
        "value": "10^-6",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In one embodiment, the anti-4-1 BB antibody binds to an unrelated, non-4-1 BB protein to a lesser extent thanAbout 10% of the binding of the antibody to 4-1BB, as measured, for example, by Radioimmunoassay (RIA) or flow cytometry (FACS).\nIn certain embodiments, an antibody that binds 4-1BB has a concentration of 1. Mu.M, 100nM, 10nM, 1nM, 0.1nM, 0.01nM, or 0.001nM (e.g., 10)  <sup>-6</sup> M or less, e.g. 10 <sup>-68</sup> M to 10 <sup>-13</sup> M, e.g. 10 <sup>-8</sup> M to 10 <sup>-10</sup> Dissociation constant (K) of M) <sub>D</sub> )"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "4-1BB",
        "binding_metric": "Kd",
        "value": "10^-68",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In one embodiment, the anti-4-1 BB antibody binds to an unrelated, non-4-1 BB protein to a lesser extent thanAbout 10% of the binding of the antibody to 4-1BB, as measured, for example, by Radioimmunoassay (RIA) or flow cytometry (FACS).\nIn certain embodiments, an antibody that binds 4-1BB has a concentration of 1. Mu.M, 100nM, 10nM, 1nM, 0.1nM, 0.01nM, or 0.001nM (e.g., 10)  <sup>-6</sup> M or less, e.g. 10 <sup>-68</sup> M to 10 <sup>-13</sup> M, e.g. 10 <sup>-8</sup> M to 10 <sup>-10</sup> Dissociation constant (K) of M) <sub>D</sub> )"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "4-1BB",
        "binding_metric": "Kd",
        "value": "10^-13",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In one embodiment, the anti-4-1 BB antibody binds to an unrelated, non-4-1 BB protein to a lesser extent thanAbout 10% of the binding of the antibody to 4-1BB, as measured, for example, by Radioimmunoassay (RIA) or flow cytometry (FACS).\nIn certain embodiments, an antibody that binds 4-1BB has a concentration of 1. Mu.M, 100nM, 10nM, 1nM, 0.1nM, 0.01nM, or 0.001nM (e.g., 10)  <sup>-6</sup> M or less, e.g. 10 <sup>-68</sup> M to 10 <sup>-13</sup> M, e.g. 10 <sup>-8</sup> M to 10 <sup>-10</sup> Dissociation constant (K) of M) <sub>D</sub> )"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "4-1BB",
        "binding_metric": "Kd",
        "value": "10^-8",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In one embodiment, the anti-4-1 BB antibody binds to an unrelated, non-4-1 BB protein to a lesser extent thanAbout 10% of the binding of the antibody to 4-1BB, as measured, for example, by Radioimmunoassay (RIA) or flow cytometry (FACS).\nIn certain embodiments, an antibody that binds 4-1BB has a concentration of 1. Mu.M, 100nM, 10nM, 1nM, 0.1nM, 0.01nM, or 0.001nM (e.g., 10)  <sup>-6</sup> M or less, e.g. 10 <sup>-68</sup> M to 10 <sup>-13</sup> M, e.g. 10 <sup>-8</sup> M to 10 <sup>-10</sup> Dissociation constant (K) of M) <sub>D</sub> )"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "4-1BB",
        "binding_metric": "Kd",
        "value": "10^-10",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In one embodiment, the anti-4-1 BB antibody binds to an unrelated, non-4-1 BB protein to a lesser extent thanAbout 10% of the binding of the antibody to 4-1BB, as measured, for example, by Radioimmunoassay (RIA) or flow cytometry (FACS).\nIn certain embodiments, an antibody that binds 4-1BB has a concentration of 1. Mu.M, 100nM, 10nM, 1nM, 0.1nM, 0.01nM, or 0.001nM (e.g., 10)  <sup>-6</sup> M or less, e.g. 10 <sup>-68</sup> M to 10 <sup>-13</sup> M, e.g. 10 <sup>-8</sup> M to 10 <sup>-10</sup> Dissociation constant (K) of M) <sub>D</sub> )"
    },
    {
        "molecule_name": "Immunoglobulins",
        "protein_target_name": "CD20",
        "binding_metric": "Kd",
        "value": "10^-8",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, antibodies that bind CD20 have a concentration of 1. Mu.M, 100nM, 10nM, 1nM, 0.1nM, 0.01nM, or 0.001nM (e.g., 10) <sup>-8</sup> M or less, e.g. 10 <sup>-8</sup> M to 10 <sup>-13</sup> M, e.g. 10 <sup>-9</sup> M to 10 <sup>-13</sup> M) dissociation constant (Kd). \nThe degree of binding of the off, non-CD 20 protein is less than about 10% of the binding of the antibody to CD20, as measured, for example, by Radioimmunoassay (RIA)."
    },
    {
        "molecule_name": "Immunoglobulins",
        "protein_target_name": "CD20",
        "binding_metric": "Kd",
        "value": "10^-9",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, antibodies that bind CD20 have a concentration of 1. Mu.M, 100nM, 10nM, 1nM, 0.1nM, 0.01nM, or 0.001nM (e.g., 10) <sup>-8</sup> M or less, e.g. 10 <sup>-8</sup> M to 10 <sup>-13</sup> M, e.g. 10 <sup>-9</sup> M to 10 <sup>-13</sup> M) dissociation constant (Kd). \nThe degree of binding of the off, non-CD 20 protein is less than about 10% of the binding of the antibody to CD20, as measured, for example, by Radioimmunoassay (RIA)."
    },
    {
        "molecule_name": "Immunoglobulins",
        "protein_target_name": "CD20",
        "binding_metric": "Kd",
        "value": "10^-13",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, antibodies that bind CD20 have a concentration of 1. Mu.M, 100nM, 10nM, 1nM, 0.1nM, 0.01nM, or 0.001nM (e.g., 10) <sup>-8</sup> M or less, e.g. 10 <sup>-8</sup> M to 10 <sup>-13</sup> M, e.g. 10 <sup>-9</sup> M to 10 <sup>-13</sup> M) dissociation constant (Kd). \nThe degree of binding of the off, non-CD 20 protein is less than about 10% of the binding of the antibody to CD20, as measured, for example, by Radioimmunoassay (RIA)."
    },
    {
        "molecule_name": "Immunoglobulins",
        "protein_target_name": "CD20",
        "binding_metric": "Kd",
        "value": "1",
        "unit": "Mu.M",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, antibodies that bind CD20 have a concentration of 1. Mu.M, 100nM, 10nM, 1nM, 0.1nM, 0.01nM, or 0.001nM (e.g., 10) <sup>-8</sup> M or less, e.g. 10 <sup>-8</sup> M to 10 <sup>-13</sup> M, e.g. 10 <sup>-9</sup> M to 10 <sup>-13</sup> M) dissociation constant (Kd). \nThe degree of binding of the off, non-CD 20 protein is less than about 10% of the binding of the antibody to CD20, as measured, for example, by Radioimmunoassay (RIA)."
    },
    {
        "molecule_name": "Immunoglobulins",
        "protein_target_name": "CD20",
        "binding_metric": "Kd",
        "value": "100",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, antibodies that bind CD20 have a concentration of 1. Mu.M, 100nM, 10nM, 1nM, 0.1nM, 0.01nM, or 0.001nM (e.g., 10) <sup>-8</sup> M or less, e.g. 10 <sup>-8</sup> M to 10 <sup>-13</sup> M, e.g. 10 <sup>-9</sup> M to 10 <sup>-13</sup> M) dissociation constant (Kd). \nThe degree of binding of the off, non-CD 20 protein is less than about 10% of the binding of the antibody to CD20, as measured, for example, by Radioimmunoassay (RIA)."
    },
    {
        "molecule_name": "Immunoglobulins",
        "protein_target_name": "CD20",
        "binding_metric": "Kd",
        "value": "10",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, antibodies that bind CD20 have a concentration of 1. Mu.M, 100nM, 10nM, 1nM, 0.1nM, 0.01nM, or 0.001nM (e.g., 10) <sup>-8</sup> M or less, e.g. 10 <sup>-8</sup> M to 10 <sup>-13</sup> M, e.g. 10 <sup>-9</sup> M to 10 <sup>-13</sup> M) dissociation constant (Kd). \nThe degree of binding of the off, non-CD 20 protein is less than about 10% of the binding of the antibody to CD20, as measured, for example, by Radioimmunoassay (RIA)."
    },
    {
        "molecule_name": "Immunoglobulins",
        "protein_target_name": "CD20",
        "binding_metric": "Kd",
        "value": "1",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, antibodies that bind CD20 have a concentration of 1. Mu.M, 100nM, 10nM, 1nM, 0.1nM, 0.01nM, or 0.001nM (e.g., 10) <sup>-8</sup> M or less, e.g. 10 <sup>-8</sup> M to 10 <sup>-13</sup> M, e.g. 10 <sup>-9</sup> M to 10 <sup>-13</sup> M) dissociation constant (Kd). \nThe degree of binding of the off, non-CD 20 protein is less than about 10% of the binding of the antibody to CD20, as measured, for example, by Radioimmunoassay (RIA)."
    },
    {
        "molecule_name": "Immunoglobulins",
        "protein_target_name": "CD20",
        "binding_metric": "Kd",
        "value": "0.1",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, antibodies that bind CD20 have a concentration of 1. Mu.M, 100nM, 10nM, 1nM, 0.1nM, 0.01nM, or 0.001nM (e.g., 10) <sup>-8</sup> M or less, e.g. 10 <sup>-8</sup> M to 10 <sup>-13</sup> M, e.g. 10 <sup>-9</sup> M to 10 <sup>-13</sup> M) dissociation constant (Kd). \nThe degree of binding of the off, non-CD 20 protein is less than about 10% of the binding of the antibody to CD20, as measured, for example, by Radioimmunoassay (RIA)."
    },
    {
        "molecule_name": "Immunoglobulins",
        "protein_target_name": "CD20",
        "binding_metric": "Kd",
        "value": "0.01",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, antibodies that bind CD20 have a concentration of 1. Mu.M, 100nM, 10nM, 1nM, 0.1nM, 0.01nM, or 0.001nM (e.g., 10) <sup>-8</sup> M or less, e.g. 10 <sup>-8</sup> M to 10 <sup>-13</sup> M, e.g. 10 <sup>-9</sup> M to 10 <sup>-13</sup> M) dissociation constant (Kd). \nThe degree of binding of the off, non-CD 20 protein is less than about 10% of the binding of the antibody to CD20, as measured, for example, by Radioimmunoassay (RIA)."
    },
    {
        "molecule_name": "Immunoglobulins",
        "protein_target_name": "CD20",
        "binding_metric": "Kd",
        "value": "0.001",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "In certain embodiments, antibodies that bind CD20 have a concentration of 1. Mu.M, 100nM, 10nM, 1nM, 0.1nM, 0.01nM, or 0.001nM (e.g., 10) <sup>-8</sup> M or less, e.g. 10 <sup>-8</sup> M to 10 <sup>-13</sup> M, e.g. 10 <sup>-9</sup> M to 10 <sup>-13</sup> M) dissociation constant (Kd). \nThe degree of binding of the off, non-CD 20 protein is less than about 10% of the binding of the antibody to CD20, as measured, for example, by Radioimmunoassay (RIA)."
    },
    {
        "molecule_name": "Atezolizumab ",
        "protein_target_name": "human PD-L1",
        "binding_metric": "KD",
        "value": "1.0x10^-8",
        "unit": "mol/l",
        "is_logarithmic": false,
        "raw_mentions": "The term \"anti-PD-L1 antibody\" or \"antibody that binds human PD-L1\" or \"antibody that specifically binds human PD-L1\" or \"antagonistic anti-PD-L1\" means a KD of 1.0x10 <sup>-8</sup> mol/l or less, in one aspect KD of 1.0x10 <sup>-9</sup> mol/L or less.\nThe term \"anti-PD-1 antibody\" or \"antibody that binds to human PD-1\" or \"antibody that specifically binds to human PD-1\" or \"antagonistic anti-PD-1\" refers to a polypeptide having a KD of 1.0x10 <sup>-8</sup> mol/l or less, in one aspect KD of 1.0x10 <sup>-9</sup> mol/l or less."
    },
    {
        "molecule_name": "Atezolizumab ",
        "protein_target_name": "human PD-L1",
        "binding_metric": "KD",
        "value": "1.0x10^-9",
        "unit": "mol/L",
        "is_logarithmic": false,
        "raw_mentions": "The term \"anti-PD-L1 antibody\" or \"antibody that binds human PD-L1\" or \"antibody that specifically binds human PD-L1\" or \"antagonistic anti-PD-L1\" means a KD of 1.0x10 <sup>-8</sup> mol/l or less, in one aspect KD of 1.0x10 <sup>-9</sup> mol/L or less.\nThe term \"anti-PD-1 antibody\" or \"antibody that binds to human PD-1\" or \"antibody that specifically binds to human PD-1\" or \"antagonistic anti-PD-1\" refers to a polypeptide having a KD of 1.0x10 <sup>-8</sup> mol/l or less, in one aspect KD of 1.0x10 <sup>-9</sup> mol/l or less."
    },
    {
        "molecule_name": "Nivolumab",
        "protein_target_name": "human PD-1",
        "binding_metric": "KD",
        "value": "1.0x10^-8",
        "unit": "mol/l",
        "is_logarithmic": false,
        "raw_mentions": "The term \"anti-PD-L1 antibody\" or \"antibody that binds human PD-L1\" or \"antibody that specifically binds human PD-L1\" or \"antagonistic anti-PD-L1\" means a KD of 1.0x10 <sup>-8</sup> mol/l or less, in one aspect KD of 1.0x10 <sup>-9</sup> mol/L or less.\nThe term \"anti-PD-1 antibody\" or \"antibody that binds to human PD-1\" or \"antibody that specifically binds to human PD-1\" or \"antagonistic anti-PD-1\" refers to a polypeptide having a KD of 1.0x10 <sup>-8</sup> mol/l or less, in one aspect KD of 1.0x10 <sup>-9</sup> mol/l or less."
    },
    {
        "molecule_name": "Nivolumab",
        "protein_target_name": "human PD-1",
        "binding_metric": "KD",
        "value": "1.0x10^-9",
        "unit": "mol/l",
        "is_logarithmic": false,
        "raw_mentions": "The term \"anti-PD-L1 antibody\" or \"antibody that binds human PD-L1\" or \"antibody that specifically binds human PD-L1\" or \"antagonistic anti-PD-L1\" means a KD of 1.0x10 <sup>-8</sup> mol/l or less, in one aspect KD of 1.0x10 <sup>-9</sup> mol/L or less.\nThe term \"anti-PD-1 antibody\" or \"antibody that binds to human PD-1\" or \"antibody that specifically binds to human PD-1\" or \"antagonistic anti-PD-1\" refers to a polypeptide having a KD of 1.0x10 <sup>-8</sup> mol/l or less, in one aspect KD of 1.0x10 <sup>-9</sup> mol/l or less."
    }
]